Dalton adds geographic diversification to Lonza facilities network
Lonza and Dalton Pharma Services have entered into a co-operation agreement to provide clients with fully integrated chemistry services from discovery through to commercial production.
With proximity to key customers in the North American pharmaceutical market Dalton adds geographic diversification to Lonza's facilities network that ranges from kg-lab to large-scale manufacturing capabilities (ISO, cGMP) in Visp, Switzerland and Nansha, China.
Dalton’s offering includes contract chemistry research, contract analytical services and chemical synthesis up to cGMP kg-scale as well as small-scale fill-finish activities at its site in Toronto, Canada.
Lonza said the alliance would enable seamless transition of custom small molecule projects from Dalton's kg-lab scale through to Lonza's clinical and commercial manufacturing scale.